CLINICAL_TRIALS
trial_result
· 2024-11-15
Clinical Trial Update: Preoperative Chemoradiotherapy and MK-3475 for Esophageal Squamous Cell Carcinoma (ACTS-29) [Phase 2]
Summary
This Phase 2 trial (ACTS-29) evaluating preoperative chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma has completed and posted result…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yonsei University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-11-15